In a postpartum woman, how many weeks should low‑dose (81 mg) aspirin be continued?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Low-Dose Aspirin in the Postpartum Period

Low-dose aspirin initiated for preeclampsia prevention should be continued daily until delivery and then discontinued immediately postpartum—it is not routinely continued into the postpartum period. 1, 2

Guideline-Based Recommendations on Duration

The American College of Obstetricians and Gynecologists explicitly recommends that low-dose aspirin be continued daily until delivery, not beyond. 1, 3, 2 This represents the consensus across multiple international guidelines from the USA, Canada, Ireland, New Zealand, and the UK. 1

Key Timing Points:

  • Initiation: Start between 12-16 weeks of gestation (optimally before 16 weeks) 1, 3, 2
  • Continuation: Daily through pregnancy until delivery 1, 3, 2
  • Discontinuation: At delivery—aspirin is stopped postpartum 1, 2

Rationale for Stopping at Delivery

The mechanistic basis for aspirin prophylaxis is specific to pregnancy physiology:

  • Aspirin targets defective placentation and abnormal spiral artery remodeling that occur during the first and early second trimester 1
  • Once the placenta is delivered, the pathophysiologic substrate for preeclampsia is removed 1
  • The anti-inflammatory and endothelial-protective effects are only relevant while the placenta is present 1

Important Clinical Pitfalls to Avoid

Common Misconception About Postpartum Continuation

Do not confuse pregnancy-related aspirin prophylaxis with long-term cardiovascular disease prevention. 1 The timing and indication for aspirin in preeclampsia prevention (restricted to the gestational period) differs fundamentally from its use for cardiovascular disease, where lifelong therapy may be appropriate. 1

Stopping Before Delivery

Avoid the common error of discontinuing aspirin at 36 weeks "just to be safe"—this removes protection during a high-risk period without evidence-based rationale. 1 Preeclampsia risk persists throughout pregnancy and even into the early postpartum period, with eclamptic seizures potentially developing for the first time after delivery. 1

Exception for Planned Cesarean Section

For scheduled cesarean delivery with neuraxial anesthesia, consider discontinuing aspirin 7-10 days before surgery to allow adequate platelet recovery. 4 Verify platelet count >75 × 10⁹/L immediately before spinal anesthesia. 4

Safety Profile Through Delivery

Low-dose aspirin (75-162 mg daily) does not increase risks of placental abruption, postpartum hemorrhage, fetal intracranial bleeding, or perinatal mortality when continued until delivery. 1, 4 This safety profile supports continuation through the delivery period without routine early discontinuation. 1

Special Populations Requiring Postpartum Anticoagulation

Antiphospholipid Syndrome

Women with antiphospholipid syndrome require a different approach: anticoagulation (low-molecular-weight heparin) should be continued for 6-12 weeks postpartum, though low-dose aspirin itself is typically discontinued at delivery. 1 This extended anticoagulation protects against thrombotic events in the high-risk postpartum period. 1

Summary Algorithm

  1. High-risk woman identified → Start aspirin 100-150 mg daily at 12-16 weeks 1, 3, 2
  2. Continue daily through pregnancy → No interruption until delivery 1, 3, 2
  3. At delivery → Discontinue aspirin 1, 2
  4. Postpartum → No routine continuation (0 weeks postpartum) 1, 2
  5. Exception: APS patients continue LMWH (not aspirin) for 6-12 weeks postpartum 1

References

Guideline

Aspirin Prophylaxis in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Aspirin Therapy in Morbidly Obese Twin Pregnancy with Selective Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is it safe for a woman trying to conceive to take baby aspirin (acetylsalicylic acid), 81mg, and under what circumstances is it recommended?
In a pregnant woman at increased risk for preeclampsia, should low‑dose acetyl‑salicylic acid (aspirin) be given, and if so what dose, when to start, and how long to continue?
In a 22‑year‑old G2P1 woman at 30 weeks gestation with obesity (BMI 36), prior gestational hypertension and a family history of preeclampsia, should low‑dose aspirin be initiated for preeclampsia prophylaxis?
What are the guidelines for Acetylsalicylic Acid (ASA) use in pregnant individuals?
Is it safe to stop low-dose aspirin (acetylsalicylic acid) at 34 weeks of gestation in pregnant women at high risk of preeclampsia?
What is the immediate management for a patient with acute myeloid leukemia and severe anemia who develops fever during a red blood cell transfusion while other vital signs remain stable?
What is the recommended treatment regimen for cryptosporidiosis in immunocompetent adults and children, and how should therapy be adjusted for immunocompromised patients, particularly those with HIV infection?
Did a single severe straining episode on the toilet three years ago cause irreversible damage, denervation, or permanent overstretching of the puborectalis muscle resulting in chronic constipation, urinary urgency, and dyspareunia?
What is the recommended treatment for fluoxetine (Prozac)-induced tremor?
What is the recommended way to switch an adult patient from sertraline (Zoloft) 200 mg daily to duloxetine (Cymbalta) 30 mg daily?
Can hyoscine N‑butylbromide cause ileus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.